Sometimes capital finds you. That’s what happened to Cigall Kadoch, Ph.D., assistant professor, Dana-Farber & Broad Institute. She was busy untangling the mysteries of a chromatin remodeling complex and its relationship to disease onset. She wanted to found a company, but she wanted to do it her way and with the right partner.
At about the same time, Douglas Cole, M.D., managing partner at Flagship Pioneering, was looking for a brilliant, disruptive idea to form a company on. He wanted to build a company from the ground up, working with researchers to refine an idea and validate the science. When he met Kadoch, he knew he had found what he was looking for, and Foghorn Therapeutics was born.